GOLD RESOURCE CORP

Where It Passes

Where It Falls Short

• Profitability0% pass✓ 7✗ 28▾

  No clean pass — all 16 investors flag at least one profitability criterion

  Positive EPS (10 years)10/20 years positive

  ✗GrahamPositive EPS every year for 10 years

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Net Income Positive (10+ years)11/20 years positive

  ✗BuffettPositive every year for 10+ years

  ROE (up to 5-year arithmetic mean)-50.4%

  ✗Buffett> 15% arithmetic mean (app rule)

  Operating Margin (10-yr trend)-3.1% (latest)

  ✗BuffettStable or rising over 10 years

  Free Cash Flow Proxy$-6.5M

  ✗BuffettPositive and growing

  Earnings Variance (10-yr CoV)16.82

  ✗BuffettCoV < 0.3

  Retained Earnings Effectiveness

  ✗Buffett$1 retained -> > $1 market value created

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR

  ✗Lynch15-30% (Fast Grower); > 0% to pass

  ROE13.5%

  ✗Lynch> 15%

  EBIT / Enterprise Value-0.6%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=-0.6%, ROC=-2.2%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Net Income / Total Assets-3.51%

  ✗PiotroskiROA > 0

  ROA Change YoY-38.73% -> -3.51% (delta: +35.22%)

  ✓PiotroskiCurrent ROA > Prior ROA

  (CFO / Total Assets) vs ROACFO/Assets=11.79%, ROA=-3.51%

  ✓PiotroskiCFO/Assets > ROA

  Gross Margin Change YoY-31.2% -> 26.8%

  ✓PiotroskiImproved YoY

  Pre-Tax Income / Revenue-6.9%

  ✗Dreman>= 8%

  Net Income / Shareholders' Equity13.5%

  ✓Dreman> 12%

  Margin of SafetyP/B=11.8x

  ✗PabraiP/B < 1.5 or P/E < 15

  Return on Equity-83.9% (3-yr avg)

  ✗AkreROE > 20% (3-year avg)

  Discount to Intrinsic ValueN/A (negative normalized EPS)

  ✗Marks>= 20% below intrinsic value

  Positive Net Income Frequency11/18 years positive

  ✓MarksPositive net income in >= 7 of last 10 years

  Operating Income / Revenue10.8%

  ✗Ackman>= 15%

  Net Income / Shareholders Equity13.5%

  ✗Ackman>= 15%

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Operating Margin Trend-30.7% (2023) -> -3.1% (2025)

  ✓TempletonNon-negative operating-margin trend over 3 years

  Revenue growth vs. gross and operating margin trendgross margin -5.3% -> 26.8%, operating margin -30.7% -> -3.1%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  Net income / market capitalization+1.21%; #2927/6340 (top 46.2%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Gross profit / total assets+24.07%; #1787/3702 (top 48.3%)

  ✗AsnessTop 30% of eligible cross-section

  Net income / positive book equity+13.52%; #1322/5226 (top 25.3%)

  ✓AsnessTop 30% of eligible cross-section

  Negative 5-year standard deviation of ROA-0.1496; #3933/5884 (top 66.8%)

  ✗AsnessTop 30% of eligible cross-section

  3-5 Year Diluted EPS CAGR6.6% over 5 years

  ✗Neff7%-20% annualized

  Positive Diluted-EPS Years6/10 years positive

  ✗Schloss>= 70% positive over 5-10 observed years (app rule)
• Valuation0% pass✗ 28▾

  All 13 investors flag GORO's valuation

  Price / 3-yr avg EPS

  ✗Graham<= 15x

  Price-to-Book Ratio11.8x

  ✗Graham<= 1.5x

  P/E x P/B

  ✗Graham<= 22.5

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  EBIT / Enterprise Value-0.6%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=-0.6%, ROC=-2.2%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Price / EPS

  ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)

  Price / (CFO / Shares)24.0x

  ✗Dreman< 8x

  Price / Book Value per Share11.8x

  ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)

  Valuation ReasonablenessOE Yield=-2.9%

  ✗MungerP/E < 25 or Owner Earnings Yield > 5%

  P/E or FCF YieldFCF Yield=0.1%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  P/B or P/E vs. Historical AverageP/B=11.8x

  ✗MarksP/E < 15 or P/B < 2.0

  Discount to Intrinsic ValueN/A (negative normalized EPS)

  ✗Marks>= 20% below intrinsic value

  Price / FCF per Share808.8x

  ✗Ackman<= 25

  Price vs. Trailing Low503% of trailing low ($0.64)

  ✗Templeton<= 120% of trailing low (certified split-adjusted live window)

  Net income / market capitalization+1.21%; #2927/6340 (top 46.2%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Positive book equity / market capitalization+0.0897; #4801/6449 (top 74.4%)

  ✗AsnessTop 30% of eligible cross-section

  Price / Diluted EPS

  ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)

  (EPS CAGR % + Dividend Yield %) / P/E

  ✗Neff> 0.7 (Neff's published traditional edge)

  Price / Tangible Book Value per Share11.83x

  ✗SchlossP/TBV <= 1.00x (app cutoff)

  Book Value per Share Change

  ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)

  Revenue / market capitalization+0.2413; #3588/5247 (top 68.4%)

  ✗OshaughnessyTop 10% of eligible cross-section

  (Operating cash flow - capex) / market capitalization+1.79%; #2287/4519 (top 50.6%)

  ✗OshaughnessyTop 10% of eligible cross-section

  Trailing six-month price return through the evaluation date-45.61%; #5003/6202 (top 80.7%)

  ✗OshaughnessyTop 10% of eligible cross-section
• Verdicts0% pass✗ 14▾

  Split decision: 13 FAIL · 3 NEUTRAL

  Overall verdict

  ✗GrahamFAIL (2/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)✗GreenblattRank #1865•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (0/6)✗MarksFAIL (2/5)✗AckmanFAIL (1/9)✗TempletonFAIL (2/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)
• Valuation models0% pass✗ 3▾

  GORO overvalued: all 3 models price fair value below $3.22 (median $0.05)

  Munger fair value$0.05

  ✗Munger-6340.0% margin vs $3.22

  Akre fair value$0.23

  ✗Akre-1300.0% margin vs $3.22

  Ackman fair value$0.03

  ✗Ackman-10633.3% margin vs $3.22
• Debt & Leverage8% pass✓ 3✗ 12▾

  11 of 12 flag GORO's debt & leverage — Graham, Buffett, Lynch +8 more

  LT Debt vs Net Current Assets

  ✗GrahamLT Debt <= Net Current Assets

  Debt/Equity & Interest Coverage

  ✗BuffettD/E < 0.5 AND Interest Coverage > 5x

  Total Debt / Equity

  ✗Lynch< 0.33

  Cash - Long-term Debt

  ✗LynchPositive preferred

  LT Debt / Total Assets Change0.00% -> 0.00%

  ✓PiotroskiDecreased YoY

  Current Assets / Current Liabilities3.33

  ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)

  Total Debt / Shareholders' Equity

  ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x

  Debt Levels

  ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3

  Interest Coverage & Debt/EBITDAIC=-16.9x, D/EBITDA=N/A

  ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x

  Total Debt / Shareholders Equity

  ✗Ackman<= 1.0

  Negative debt-to-equity (higher means less debt)

  ✗AsnessTop 30% of eligible cross-section
• Growth13% pass✓ 2✗ 11▾

  7 of 8 flag GORO's growth — Graham, Lynch, Dreman +4 more

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR

  ✗Lynch15-30% (Fast Grower); > 0% to pass

  Inventory Growth vs Revenue GrowthInv: 36.8% vs Rev: 121.2%

  ✓LynchInventory growth < Revenue growth

  EPS Growth Direction$-0.78 (2009) -> $-0.05 (2025)

  ✗DremanPositive over recent years

  EPS CAGR-20.0% CAGR over 10 years

  ✗Dreman> 5% annualized

  Positive Net Income Frequency11/18 years positive

  ✓MarksPositive net income in >= 7 of last 10 years

  3yr Median Revenue Growth-29.6%

  ✗Ackman>= 5%

  Positive EPS Growth Frequency2/5 years with positive EPS growth

  ✗AckmanPositive EPS growth in >= 3 of last 5 years

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Revenue growth vs. gross and operating margin trendgross margin -5.3% -> 26.8%, operating margin -30.7% -> -3.1%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  5-year Revenue CAGR1.9%

  ✗SleepCAGR > 7%

  3-5 Year Diluted EPS CAGR6.6% over 5 years

  ✗Neff7%-20% annualized
• Cash Flow50% pass✓ 6✗ 6▾

  5 of 10 pass — Buffett, Dreman, Pabrai +2 more object

  Free Cash Flow Proxy$-6.5M

  ✗BuffettPositive and growing

  FCF Positive and Growing$9.7M

  ✓LynchPositive and growing

  Operating Cash Flow$21.7M

  ✓PiotroskiCFO > 0

  (CFO / Total Assets) vs ROACFO/Assets=11.79%, ROA=-3.51%

  ✓PiotroskiCFO/Assets > ROA

  Price / (CFO / Shares)24.0x

  ✗Dreman< 8x

  P/E or FCF YieldFCF Yield=0.1%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  FCF Positive9/17 years FCF positive

  ✓MarksPositive FCF in majority of recent years

  (OCF - CapEx) / Market Cap1.9%

  ✗Ackman>= 4%

  Price / FCF per Share808.8x

  ✗Ackman<= 25

  Positive Operating Cash Flow frequency13/17 years positive

  ✓SleepPositive OCF in >= 70% of available years

  Operating Cash Flow - Capital Expenditures$9.7M

  ✓Neff> $0 (app proxy for a strong fundamental case)

  (Operating cash flow - capex) / market capitalization+1.79%; #2287/4519 (top 50.6%)

  ✗OshaughnessyTop 10% of eligible cross-section
• Efficiency50% pass✓ 6✗ 5▾

  4 of 8 pass — Greenblatt, Munger, Akre +1 more object

  Current Ratio3.33

  ✓Graham>= 2.0

  ROIC (3-5 yr avg)12.8%

  ✓Buffett> 10%

  ROIC - WACC+2.8%

  ✓BuffettPositive (WACC = 10%)

  EBIT / (NWC + Net Fixed Assets)-2.2%

  ✗Greenblatt> 25%

  Current Ratio Change YoY1.14 -> 2.85

  ✓PiotroskiIncreased YoY

  Revenue / Total Assets Change YoY0.45x -> 0.54x

  ✓PiotroskiImproved YoY

  Current Assets / Current Liabilities3.33

  ✓Dreman> 1.5

  Return on Invested Capital

  ✗Munger> 15%

  ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable

  ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each

  Reinvestment Rate x ROIC

  ✗AkreReinvestment Rate * ROIC > 10%

  ROIC (5-year)

  ✗SleepROIC > 12% in a majority of years